The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase--GW311616A a development candidate.EBI
Glaxowellcome Medicines Research Centre
Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.EBI
Glaxowellcome Medicines Research Centre
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactams.EBI
Glaxowellcome Medicines Research Centre
The discovery and synthesis of highly potent, A2a receptor agonists.EBI
Glaxowellcome Medicines Research Centre
2-chloro-3-substituted-1,4-naphthoquinone inactivators of human cytomegalovirus protease.EBI
Glaxowellcome Medicines Research Centre
Syntheses of trans-5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles and trans-5-oxo-hexahydro-furo[3,2-b]pyrroles (pyrrolidine trans-lactams and trans-lactones): new pharmacophores for elastase inhibition.EBI
Glaxowellcome Medicines Research Centre